ATE255419T1 - Für den vogelembryo geeignete multivalente impfstoffe - Google Patents

Für den vogelembryo geeignete multivalente impfstoffe

Info

Publication number
ATE255419T1
ATE255419T1 AT98926269T AT98926269T ATE255419T1 AT E255419 T1 ATE255419 T1 AT E255419T1 AT 98926269 T AT98926269 T AT 98926269T AT 98926269 T AT98926269 T AT 98926269T AT E255419 T1 ATE255419 T1 AT E255419T1
Authority
AT
Austria
Prior art keywords
multivalent
poultry
multivalent vaccines
vaccines suitable
bird embryo
Prior art date
Application number
AT98926269T
Other languages
English (en)
Inventor
Jagdev M Sharma
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Application granted granted Critical
Publication of ATE255419T1 publication Critical patent/ATE255419T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98926269T 1997-06-12 1998-06-04 Für den vogelembryo geeignete multivalente impfstoffe ATE255419T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/874,103 US6048535A (en) 1997-06-12 1997-06-12 Multivalent in ovo avian vaccine
PCT/US1998/011470 WO1998056413A1 (en) 1997-06-12 1998-06-04 Multivalent in ovo avian vaccine

Publications (1)

Publication Number Publication Date
ATE255419T1 true ATE255419T1 (de) 2003-12-15

Family

ID=25362980

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98926269T ATE255419T1 (de) 1997-06-12 1998-06-04 Für den vogelembryo geeignete multivalente impfstoffe

Country Status (9)

Country Link
US (2) US6048535A (de)
EP (1) EP0996464B1 (de)
JP (1) JP2002504117A (de)
CN (1) CN1132628C (de)
AT (1) ATE255419T1 (de)
AU (1) AU7814498A (de)
CA (1) CA2301196A1 (de)
DE (1) DE69820265D1 (de)
WO (1) WO1998056413A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07206705A (ja) * 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
DK0831897T3 (da) * 1995-06-07 2001-04-30 Pfizer In ovo-vaccination mod coccidiosis
US6048535A (en) * 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
US20070269456A1 (en) * 2001-11-05 2007-11-22 Lasher Alfred W DNA-based plasmid formulations and vaccines and prophylactics containing the same
US20030228327A1 (en) * 2001-11-05 2003-12-11 Lasher Alfred W. DNA-based plasmid formulations and vaccines and prophylactics containing the same
US20040146530A1 (en) * 2002-01-30 2004-07-29 Sharma Jagdev M Avian vaccine effective against infectious bursal disease virus
US7037506B2 (en) * 2002-03-08 2006-05-02 Schweltzer Chemical Corporation Ltd. Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry
US7029681B2 (en) 2002-03-08 2006-04-18 Schweitzer Chemical Corporation Multiple and multivalent DNA vaccines in ovo
AU2003298578A1 (en) * 2002-09-16 2004-04-23 Wyeth Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor
ES2422885T3 (es) 2003-12-03 2013-09-16 Zoetis P Llc Vacunación in ovo de campylobacter en especies aviares
US20060196428A1 (en) * 2005-03-03 2006-09-07 Correa Rafael S Method for improving chick hatchability
MY149604A (en) * 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine
CN101460192A (zh) * 2006-03-30 2009-06-17 恩布里克斯公司 家禽疫苗接种的方法和组合物
WO2008076518A2 (en) * 2006-10-25 2008-06-26 University Of Georgia Research Foundation, Inc. Reovirus compositions and methods of use
GB2451428A (en) * 2007-07-25 2009-02-04 Pliva Hrvatska D O O Process for preparing an in ovo combination viral vaccine
WO2010130374A1 (en) 2009-05-14 2010-11-18 Bayer Animal Health Gmbh Enhanced immune response in avian species
US8524249B2 (en) 2009-12-15 2013-09-03 University Of Saskatchewan Vaccines for inclusion body hepatitis
BR112013002525A2 (pt) * 2010-08-02 2016-05-31 Univ Georgia vírus da laringotraqueíte infecciosa (iltv) modificado e usos do mesmo
EP2654785B1 (de) 2010-12-22 2019-03-20 Bayer Intellectual Property GmbH Erhöhte immunreaktion bei rindergattungen
RU2593950C2 (ru) 2011-10-21 2016-08-10 Интервет Интернэшнл Б.В. Рекомбинантный непатогенный mdv-вектор, обеспечивающий полиспецифический иммунитет
US8932604B2 (en) 2011-10-21 2015-01-13 Intervet Inc. Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
WO2014077096A1 (ja) * 2012-11-15 2014-05-22 一般財団法人化学及血清療法研究所 ベクターワクチンおよび生ワクチンの併用による感染症の予防方法
MX2016010993A (es) 2014-02-28 2017-05-01 Bayer Animal Health Gmbh Plasmidos inmunoestimuladores.
WO2016020730A1 (es) * 2014-08-08 2016-02-11 Laboratorio Avi-Mex, S.A. De C.V. Vacuna en vector recombinante de adenovirus aviar serotipo 9
AU2017274332B2 (en) 2016-06-02 2024-06-27 Zoetis Services Llc Vaccine against infectious bronchitis
WO2019010135A1 (en) 2017-07-05 2019-01-10 Arizona Board Of Regents On Behalf Of Arizona State University VACCINE AGAINST NECROTIC ENERTITIES IN POULTRY
US11464849B2 (en) 2019-09-11 2022-10-11 Zoetis Services Llc Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4040388A (en) * 1976-02-27 1977-08-09 Agrimatic Corporation Method and apparatus for automatic egg injection
US4458630A (en) * 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
US4882148A (en) 1987-06-18 1989-11-21 Corvita Corporation Crack prevention and improved thrombogenicity of implanted prostheses by sulfonation
ES2070997T3 (es) * 1989-12-04 1995-06-16 Akzo Nobel Nv Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
US5525342A (en) * 1994-05-20 1996-06-11 Akzo Nobel, N.V. Reovirus strain 2177 and vaccine containing same
MX9700170A (es) * 1994-06-20 1997-04-30 Los Estados Unidos De America Inmunizacion in ovo de embriones de aves con vacunas de emulsion en aceite.
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
US5733556A (en) * 1995-10-18 1998-03-31 Akzo Nobel N.V. Newcastle disease virus combination vaccine
US6048535A (en) * 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine

Also Published As

Publication number Publication date
EP0996464B1 (de) 2003-12-03
US6406702B1 (en) 2002-06-18
CN1132628C (zh) 2003-12-31
CN1261283A (zh) 2000-07-26
CA2301196A1 (en) 1998-12-17
DE69820265D1 (de) 2004-01-15
WO1998056413A1 (en) 1998-12-17
JP2002504117A (ja) 2002-02-05
EP0996464A1 (de) 2000-05-03
US6048535A (en) 2000-04-11
AU7814498A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
ATE255419T1 (de) Für den vogelembryo geeignete multivalente impfstoffe
ATE411043T1 (de) Verfahren von dna-impfung
PT714444E (pt) Atenuacao de um epitopo imunodominante de um antigenio para utilizacao em vacinas e imunoterapias para plantas, animais e homens
DK0912194T3 (da) Polynucleotid-vaccineformulering, især til behandling af respiratorisk sygdom hos kvæg
BRPI0509104A (pt) métodos e aparelho para injeção por jato automática de ovos de aves
UA41381C2 (uk) Спосіб вакцинації птиці in ovo проти кокцидіозу
ATE166530T1 (de) Vorrichtung zur frühembryonalen in ovo injektion
ES2102368T3 (es) Conjugado de vacuna para el tratamiento de las enfermedades de las aves.
PL338118A1 (en) Bird's retrovirus and method of obtaining same, poultry protecting vaccine and method of obtaining same as well as method of controlling a poultry disease
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
ES2098788T3 (es) Nueva bacteria que provoca enfermedades en las aves y vacuna derivada de esta bacteria.
DK0626008T3 (da) Vaccine, der som en adjuvans indeholder acemannan
WO2004030614A3 (en) Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor
HUP0402098A2 (hu) Baromfibetegségeket okozó új baktérium és ebből származó vakcina
MX9700170A (es) Inmunizacion in ovo de embriones de aves con vacunas de emulsion en aceite.
Sharma Multivalent in ovo avian vaccine
BR9812066A (pt) Processo para tratamento ou prevenção de infecção entérica ou respiratória bacteriana em um animal de criação
DE69331459D1 (de) Parenterale immunisierung gegen rotavirus
Reynolds Method to provide artificial passive immunity in birds
AR007611A1 (es) Linea celular de pollo infectada con virus de la enfermedad de marek perdurable, metodo para producir la linea celular, vacuna para aves y lineacelular de herpesvirus de la enfermedad de marek
RU2020142931A (ru) Вакцинация против цирковирусов свиней
ES1042341Y (es) Canula para inseminacion artificial de ganado porcino.
ES2085025T3 (es) Composicion vacunante para prevenir en el animal el aborto causado por chlamydia psitacci.
Meyer et al. Prevention and control of Salmonella infections among farm animals in GDR.
WO2005049077A3 (en) Avian vaccine effective against infectious bursal disease virus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties